Literature DB >> 2324549

Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis.

P Pisa1, M Gennene, O Söder, T Ottenhoff, M Hansson, R Kiessling.   

Abstract

It has been suggested that tumor necrosis factor alpha (TNF alpha) may serve as an important antigen-independent host defense mechanism against parasitic organisms. Sera from 66 patients with leishmaniasis and 68 patients with leprosy, all from Ethiopia, were tested for TNF alpha using an enzyme-linked immunoassay. Sera from patients with the multi-parasitic/bacillary type of disease (visceral or diffuse cutaneous leishmaniasis and lepromatous leprosy), known to be associated with absent or low specific T cell response, contained significantly higher TNF alpha titers than those of patients with pauci-parasitic/bacillary disease (localized cutaneous leishmaniasis and nonlepromatous leprosy). High titers of TNF alpha in the absence of a functioning T cell response do not appear to confer resistance against Leishmania aethiopica and Mycobacterium leprae.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2324549     DOI: 10.1093/infdis/161.5.988

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Differential induction of cellular responses by live and dead Leishmania promastigotes in healthy donors.

Authors:  S Nylén; U Mörtberg; D Kovalenko; I Satti; K Engström; M Bakhiet; H Akuffo
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Immune reactivity to fractionated Leishmania aethiopica antigens during coinfection with human immunodeficiency virus type 1.

Authors:  S C Arya
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

3.  Selective correlation of interferon-gamma, tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor with immunoglobulin G1 and immunoglobulin G3 subclass antibody in leprosy.

Authors:  R Hussain; A Kifayet; M Dojki; H M Dockrell
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

4.  Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani.

Authors:  R Bernier; S J Turco; M Olivier; M Tremblay
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi.

Authors:  D L Defosse; R C Johnson
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Tumor necrosis factor production in patients with leprosy.

Authors:  P F Barnes; D Chatterjee; P J Brennan; T H Rea; R L Modlin
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence.

Authors:  L B Adams; Y Fukutomi; J L Krahenbuhl
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection.

Authors:  T Laskay; H G Mariam; T Y Berhane; T E Fehniger; R Kiessling
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

9.  Elevated levels of circulating tumor necrosis factor alpha in human immunodeficiency virus type 1-infected Africans living in Sweden.

Authors:  A Sönnerborg; S Ayehunie; I Julander
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

10.  Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.

Authors:  A P Cope; M Londei; N R Chu; S B Cohen; M J Elliott; F M Brennan; R N Maini; M Feldmann
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.